Algernon Pharmaceuticals Inc (AGN.CX)
0.08
0.00 (0.00%)
CAD |
CNSX |
Nov 12, 14:59
Algernon Pharmaceuticals EPS Diluted (Quarterly): -0.1975 for Nov. 30, 2022
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
November 30, 2022 | -0.1975 |
August 31, 2022 | -0.2975 |
May 31, 2022 | -0.12 |
February 28, 2022 | -0.275 |
November 30, 2021 | -0.18 |
August 31, 2021 | -0.0075 |
May 31, 2021 | -0.2525 |
February 28, 2021 | -0.4125 |
November 30, 2020 | -0.615 |
August 31, 2020 | -0.6775 |
May 31, 2020 | -1.00 |
February 29, 2020 | -0.25 |
November 30, 2019 | -0.0754 |
August 31, 2019 | -0.25 |
May 31, 2019 | -0.25 |
Date | Value |
---|---|
February 28, 2019 | -0.25 |
November 30, 2018 | -0.25 |
August 31, 2018 | -0.50 |
May 31, 2018 | -0.3442 |
February 28, 2018 | -0.1418 |
November 30, 2017 | -0.1716 |
August 31, 2017 | 0.50 |
May 31, 2017 | -0.50 |
February 28, 2017 | -0.50 |
November 30, 2016 | -0.50 |
August 31, 2016 | 0.00 |
May 31, 2016 | -0.604 |
February 29, 2016 | -2.00 |
November 30, 2015 | -13.00 |
May 31, 2015 | -1.50 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.00
Minimum
May 2020
-0.0075
Maximum
Aug 2021
-0.3354
Average
-0.2525
Median
May 2021
EPS Diluted (Quarterly) Benchmarks
Biocure Technology Inc | -0.0022 |
Core One Labs Inc | -0.02 |
Restart Life Sciences Corp | -0.0031 |
Nanosphere Health Sciences Inc | -0.0137 |
Lobe Sciences Ltd | -0.0027 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -1.88M |
Total Expenses (Quarterly) | 1.880M |